Vedere Bio

0 followers

‌

Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Daniel Zimmer

Senior Director, Program Lead

Ellen Zyrkowski

Associate Director, HR & Communications

Soraya Bekkali, MD

Non Executive Director

Xiaozhi Ren (任小峙) Ph.D.

Director, CMC, Cell Line and Process Development

Karen Guerin

Senior Director, Discovery Research

Teams

Leadership Team

2 members

Research and Development

4 members

Similar companies

Gameto

4 followers

Synthekine

3 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Immunome

2 followers

Vera Therapeutics

2 followers

Abata Therapeutics

1 follower

HydroPeptide LLC

3 followers

Thermo Fisher Scientific

168 followers

Genentech

150 followers

Gilead Sciences

129 followers

Explore companies